Modeling hepatitis B-related deaths in China to achieve the WHO's impact target
It is difficult for China to achieve the WHO's impact target of 65% reduction in hepatitis B-related deaths by 2030 even we assumed the D&T rate would reach 72% in 2030 and beyond. A comprehensive scale-up of available strategies, especially innovative drugs and technologies will ensure that China achieves the target on schedule.
Authors
- Ruyi Xia (ORCID: https://orcid.org/0000-0002-7966-5907)
- Zhuoru Zou (ORCID: https://orcid.org/0000-0001-8837-0900)
- Guihua Zhuang (ORCID: https://orcid.org/0000-0001-8377-6071)
- Mingwang Shen (ORCID: https://orcid.org/0000-0003-4553-800X)
- Wenjun Liu (ORCID: https://orcid.org/0000-0002-3080-8655)
- Lei Zhang (ORCID: https://orcid.org/0000-0003-2343-084X)
- Peng Li
- Renjie Liu (ORCID: https://orcid.org/0000-0001-9897-7386)
Institutions
- Melbourne Sexual Health Centre (AU)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Alfred Health (AU)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Infectious Disease Modelling
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1016/j.idm.2025.02.010
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Ministry of Science and Technology of the People's Republic of China